188 related articles for article (PubMed ID: 23670285)
1. Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients.
Masajtis-Zagajewska A; Kurnatowska I; Wajdlich M; Jagodzińska M; Nowicki M
Int Urol Nephrol; 2013 Dec; 45(6):1733-40. PubMed ID: 23670285
[TBL] [Abstract][Full Text] [Related]
2. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
[TBL] [Abstract][Full Text] [Related]
3. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
4. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2015 Mar; 30(3):513-20. PubMed ID: 25319937
[TBL] [Abstract][Full Text] [Related]
5. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
6. Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.
Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2012 May; 55(5):1338-45. PubMed ID: 22349073
[TBL] [Abstract][Full Text] [Related]
7. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
Korish AA
Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
[TBL] [Abstract][Full Text] [Related]
8. Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.
Nauck MA; Büsing M; Orskov C; Siegel EG; Talartschik J; Baartz A; Baartz T; Hopt UT; Becker HD; Creutzfeldt W
Acta Diabetol; 1993; 30(1):39-45. PubMed ID: 8329730
[TBL] [Abstract][Full Text] [Related]
9. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM
Am J Clin Nutr; 2009 Jan; 89(1):106-113. PubMed ID: 19056578
[TBL] [Abstract][Full Text] [Related]
10. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
12. Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen MB; Christensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
J Clin Endocrinol Metab; 2014 Jul; 99(7):2457-66. PubMed ID: 24712563
[TBL] [Abstract][Full Text] [Related]
13. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
[TBL] [Abstract][Full Text] [Related]
14. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease.
Jørgensen MB; Idorn T; Rydahl C; Hansen HP; Bressendorff I; Brandi L; Wewer Albrechtsen NJ; van Hall G; Hartmann B; Holst JJ; Knop FK; Hornum M; Feldt-Rasmussen B
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31608934
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis.
Broberg B; Madsen JL; Fuglsang S; Holst JJ; Christensen KB; Rydahl C; Idorn T; Feldt-Rasmussen B; Hornum M
Neurogastroenterol Motil; 2019 Apr; 31(4):e13554. PubMed ID: 30667131
[TBL] [Abstract][Full Text] [Related]
17. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
18. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion.
Mingrone G; Nolfe G; Gissey GC; Iaconelli A; Leccesi L; Guidone C; Nanni G; Holst JJ
Diabetologia; 2009 May; 52(5):873-81. PubMed ID: 19229515
[TBL] [Abstract][Full Text] [Related]
19. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
20. Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.
Prévost G; Ducrotté P; Cailleux A; Khalfi K; Basuyau JP; Lefebvre H; Kuhn JM
Neurogastroenterol Motil; 2013 Aug; 25(8):694-9. PubMed ID: 23663508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]